This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Is Chemours (CC) Stock a Solid Choice Right Now?
by Zacks Equity Research
Chemours (CC) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Industry Rank perspective.
Schnitzer Steel Up 37% in 3 Months: What's Driving the Stock?
by Zacks Equity Research
Strong fiscal third-quarter results contributed to a rally in Schnitzer Steel's (SCHN) shares.
Westlake Chemical Up 10% in a Month: What's Driving It?
by Zacks Equity Research
Westlake Chemical's (WLK) shares are heading higher following the company's strong Q2 earnings release.
Freeport (FCX) to Divest Majority Stake in Indonesia Unit
by Zacks Equity Research
Freeport (FCX) and the Indonesian government have agreed on a framework regarding PT-FI's long-term operating rights, as the company agrees to divest a majority stake in the Indonesian unit.
5 Reasons to Add Innophos (IPHS) Stock to Your Portfolio
by Zacks Equity Research
Based on its compelling prospects, we believe Innophos (IPHS) has plenty of upside potential.
Top Ranked Growth Stocks to Buy for August 30th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, August 30th:
Innophos Declares Closure of Novel Ingredients Acquisition
by Zacks Equity Research
Innophos Holdings (IPHS) announced the closure of its acquisition deal with Novel Ingredients, creating a $0.5 billion Food, Health and Nutrition platform.
Potash Corp to Gain From Rising Demand Amid Weak Pricing
by Zacks Equity Research
While Potash Corp. (POT) faces a weak pricing environment, it should gain from healthy demand for potash. The proposed merger with Agrium should also create significant synergies.
Agrium to Buy Ag-Retail Businesses in Georgia & Florida
by Zacks Equity Research
The buyout of Southern States Cooperative's businesses is in sync with Agrium's (AGU) focus on expanding its retail distribution network in the United States.
Why Chemours Company (CC) Could Be an Impressive Growth Stock
by Zacks Equity Research
Chemours Company (CC) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.
Valmont to Divest Mining Consumables Business to Moly-Cop
by Zacks Equity Research
Valmont (VMI) entered into definitive agreement with Moly-Cop to sell its Australian mining consumables business, Donhad Pty. Ltd.
Westlake Chemical Scales New 52-Week High on Bright Prospects
by Zacks Equity Research
Westlake Chemical (WLK) shares have scaled new highs driven by strong Q2 results and recently announced dividend hike.
American Vanguard's Unit Buys Syngenta's Products in Mexico
by Zacks Equity Research
American Vanguard (AVD) strengthens its herbicide and fungicide offerings with the acquisition of Syngenta's products in Mexico.
Worthington (WOR) Adds New Fuel System, Type 3 Rail Mount
by Zacks Equity Research
Worthington (WOR) added new fuel system, Type 3 Rail Mount, which will offer similar operating experience like diesel trucks and achieve fuel economy.
6 Reasons to Add Kronos Worldwide Stock to Your Portfolio
by Zacks Equity Research
Based on its compelling prospects, we believe Kronos Worldwide (KRO) has plenty of upside potential.
Andersons (ANDE) Hits 52-Week Low: What's Taking It Down?
by Zacks Equity Research
Andersons (ANDE) hit a 52-week low of $31.15 on Aug 22. Issues in Ethanol Group and Plant Nutrient group are hurting the company's performance.
Westlake Chemical (WLK) Announces Quarterly Dividend Hike
by Zacks Equity Research
Westlake Chemical (WLK) increases quarterly dividend by 10% to 21 cents per share.
Rally Set to Resume: Buy These 5 Value Picks on the Dip
by Swarup Gupta
Morgan Stanley believes that conditions for a Bull Run remain in place.
Iamgold (IAG) Acquires Common Shares of TomaGold for $2.5M
by Zacks Equity Research
Iamgold (IAG) completes its $2.5 million strategic investment in TomaGold.
Zacks.com featured highlights: The Chemours Company, Haemonetics Corporation and The Brink's Company
by Zacks Equity Research
Zacks.com featured highlights: The Chemours Company, Haemonetics Corporation and The Brink's Company
AK Steel (AKS) Poised on Automotive Expansion Amid Headwinds
by Zacks Equity Research
While AK Steel (AKS) remains exposed to pricing and industry-related headwinds, it should gain from its efforts to grow its automotive business and improve cost structure.
Should You Get Rid of First Majestic Silver Corp. (AG) Now?
by Zacks Equity Research
First Majestic Silver Corp. (AG) has witnessed a significant price decline in the past four weeks, and has seen negative earnings estimate revisions for the current quarter and year.
3 Best Stocks with Upgraded Broker Ratings to Invest In Now
by Zacks Equity Research
Selecting stocks from the vast investment universe is not an easy task. In such a situation, sound broker advice helps to pick the right stocks.
Nucor Corp (NUE) Scoops Up St. Louis Steel Bar Maker
by Zacks Equity Research
The buyout of St. Louis Cold Drawn is in sync with Nucor's (NUE) strategy to expand its position as the market leader in cold finished bar products.
ArcelorMittal to Invest 96M Euro in Florange and Dunkerque
by Zacks Equity Research
ArcelorMittal (MT) plans to invest 67 million euros in Florange for a new production line for automotive steels and 29 million euros at Dunkerque to attain greater flexibility for high value products.